Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota: A Randomized, Placebo-Controlled, Double-Blind, Crossover Trial in Healthy Adults

NCT06920641 is registered in ClinicalTrials.gov with PepsiCo Global R&D as lead sponsor.

NCT NCT06920641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06920641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota: A Randomized, Placebo-Controlled, Double-Blind, Crossover Trial in Healthy Adults
Lead sponsor
PepsiCo Global R&D
Phase
Not applicable
Overall status
Completed
Start date
April 10, 2025
Completion date
January 19, 2026
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose intolerance, microbial colonization